O
LOGC
OrbiMed’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8,466,783
| Closed | -$2.3K | – | 135 |
|
|
2022
Q3 | $2.31K | Hold |
8,466,783
| – | – | 0.04% | 118 |
|
|
2022
Q2 | $2.97K | Hold |
8,466,783
| – | – | 0.05% | 119 |
|
|
2022
Q1 | $5.76M | Hold |
8,466,783
| – | – | 0.09% | 116 |
|
|
2021
Q4 | $19.6M | Hold |
8,466,783
| – | – | 0.25% | 86 |
|
|
2021
Q3 | $38.8M | Hold |
8,466,783
| – | – | 0.43% | 65 |
|
|
2021
Q2 | $37.6M | Hold |
8,466,783
| – | – | 0.38% | 70 |
|
|
2021
Q1 | $61.6M | Hold |
8,466,783
| – | – | 0.58% | 50 |
|
|
2020
Q4 | $64.6M | Buy |
8,466,783
+2,000,000
| +31% | +$15.3M | 0.57% | 50 |
|
|
2020
Q3 | $58.7M | Hold |
6,466,783
| – | – | 0.74% | 38 |
|
|
2020
Q2 | $54.7M | Hold |
6,466,783
| – | – | 0.77% | 42 |
|
|
2020
Q1 | $31.9M | Hold |
6,466,783
| – | – | 0.54% | 49 |
|
|
2019
Q4 | $46.6M | Hold |
6,466,783
| – | – | 0.66% | 48 |
|
|
2019
Q3 | $69.9M | Hold |
6,466,783
| – | – | 1.33% | 25 |
|
|
2019
Q2 | $84.1M | Hold |
6,466,783
| – | – | 1.3% | 22 |
|
|
2019
Q1 | $63.9M | Hold |
6,466,783
| – | – | 0.99% | 33 |
|
|
2018
Q4 | $67.3M | Buy |
+6,466,783
| New | +$67.3M | 1.24% | 25 |
|